Business Context and Reporting Period
This Form 8-K Current Report was filed by Zimmer Holdings, Inc. (now Zimmer Biomet Holdings, Inc.) on July 16, 2012. The filing addresses corporate governance changes, specifically the election of a new director to the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The primary material change reported is the appointment of Christopher B. Begley to the Board of Directors to fill a vacancy. His term is set to expire at the 2013 annual meeting of stockholders. Additionally, Mr. Begley was appointed to the Audit Committee and the Research, Innovation and Technology Committee, effective July 16, 2012.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, or management commentary regarding future financial performance. No specific risks or contingencies are disclosed in this report. The appointment was made without any arrangements or understandings between Mr. Begley and other persons. As a non-employee director, Mr. Begley will participate in standard compensation arrangements and is expected to execute the company's standard indemnification agreement.
Key Facts for Investor Verification
- Christopher B. Begley was elected to the Board of Directors on July 16, 2012.
- Mr. Begley serves on the Audit Committee and the Research, Innovation and Technology Committee.
- His director term expires at the 2013 annual meeting of stockholders.
- Compensation follows the non-employee director arrangements described in the proxy statement filed on March 23, 2012.
- This filing does not contain financial results or operational metrics.